EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure

Jad Hamze, Christopher Stone, Dwight Douglas Harris, Kelsey Muir, Keertana Yalamanchili, Nicholas C Sellke, Frank W Sellke

Vascular Pharmacology · 2025

DOI: 10.1016/j.vph.2025.107530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von Jad Hamze und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Rhode Island Hospital, Providence, RI, United States of America. Hauptthemen laut MEDLINE: Metabolic Syndrome, Sodium-Glucose Transporter 2 Inhibitors, Microvessels, Testis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for the National Institutes of Health, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study evaluates the effects of sodium-glucose cotransporter 2 (SGLT2) inhibition on testicular microvascular function and vascular signaling pathways in a swine model of metabolic syndrome (MetS) and ischemic cardiomyopathy (ICM). METHODS: Eleven male Yorkshire swine were fed a high-fat diet to induce MetS. At 11 weeks, ICM was induced by placing an ameroid constrictor around the left circumflex artery. After a two-week stabilization period, swine were randomized into a high-fat control (HFC) or canagliflozin-treated (HCAN, 300 mg/day) group for five weeks. Terminal harvests were performed to assess testicular perfusion, endothelial function markers, and pro-apoptotic signaling. RESULTS: Canagliflozin (CAN) significantly improved testicular perfusion (p = 0.0134). Molecular analysis showed a significant increase in p-AMPK/AMPK ratio (p = 0.0483), indicating enhanced metabolic and endothelial signaling, and a significant reduction in BAD/BCL2 ratio (p = 0.0095), consistent with a shift toward anti-apoptotic signaling. The p-eNOS/eNOS ratio trended upward in treated animals (p = 0.1007), suggesting potential augmentation of nitric oxide-mediated vasodilation. Total ERK expression was also increased (p = 0.0201), supporting engagement of MAPK pathways. CONCLUSION: SGLT2 inhibition improved testicular microvascular perfusion and modulated key signaling ratios, including increased p-AMPK/AMPK and reduced BAD/BCL2, with a trend toward higher p-eNOS/eNOS. These findings demonstrate that canagliflozin promotes vascular survival pathways in peripheral tissues, underscoring its vasculoprotective potential beyond the myocardium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeSodium-Glucose Transporter 2 InhibitorsMicrovesselsTestisCanagliflozinHeart FailureEndothelium, VascularMicrocirculationAnimalsMaleDisease Models, AnimalSignal TransductionSus scrofaApoptosisAMP-Activated Protein Kinases

Stichwörter der Autor:innen

Cardiometabolic diseaseEndothelial signalingPeripheral microvascular dysfunctionSGLT2 inhibitors (canagliflozin)Testicular perfusion

Substanzen

Sodium-Glucose Transporter 2 InhibitorsCanagliflozinAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Cardiovascular Research Center, Rhode Island Hospital, Providence, RI, United States of America.
  • Cardiovascular Research Center, Rhode Island Hospital, Providence, RI, United States of America; Department of Surgery, Division of Cardiothoracic Surgery, The Warren Alpert Medical School, Brown University, Providence,…
  • Case Western Reserve University Urology Institute, University Hospitals Cleveland, Case Western Reserve University, Cleveland, OH, United States of America.

Förderung

  • Foundation for the National Institutes of Health
  • National Institutes of Health

Zitieren

APA

Hamze, J., Stone, C., Harris, D. D., Muir, K., Yalamanchili, K., Sellke, N. C., & Sellke, F. W. (2025). Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107530

Vancouver

Hamze J, Stone C, Harris DD, Muir K, Yalamanchili K, Sellke NC, et al. Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107530

BibTeX
@article{Hamze2025,
  author = {Hamze, Jad and Stone, Christopher and Harris, Dwight Douglas and Muir, Kelsey and Yalamanchili, Keertana and Sellke, Nicholas C and Sellke, Frank W},
  title = {Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure},
  journal = {Vascular Pharmacology},
  year = {2025},
  doi = {10.1016/j.vph.2025.107530}
}
Kostenlos starten →